Updated December 23, 2021
"The FDA and Health Canada recently opened for industry comment new guidance from the International Conference on Harmonisation on the photosafety testing of drug compounds.
“The S10 draft guidance document clarifies some points in the current EMA and FDA guidance that are known weaknesses, based on accumulated information and experience since those documents were issued in the mid-2000s,” Doug Learn, director of photobiology at Charles River, told In-Pharmatechnologist.com."
'via Blog this'
Read the guidance (updated link):
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
Posts
No comments:
Post a Comment